1、i, F., Li, J., Liu, L., Liang, J., Wang, X., Liu, J., Cai, D., Huang, R., Zhang, J., Wang, Q., Nan, Y., Li, J., Ye, Q., Zhang, M., Xu, Q., Guo, F., Zhao, C., Liu, L., He, C., Li, Y., Wang, W., Kam, LY., Tran, S., Maeda, M., Mizuta, A., Li, Z., Dang, S., Ren, W., Zhu, Q., Cheung, R., Niu, J., Xie, W., Pan, H., Ren, H., Wu, C., Shang, J., Wang, F., Nguyen, MH, (2020). High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b. J GASTROEN HEPATOL, 36 (3), 767-774. https://doi.org/10.1111/jgh.15192IF: 3.7 Q2。

2、Li, X., Liu, X., Zhang, Y., Cheng, C., Fan, J., Zhou, J., Garstka, MA., Li, Z, (2020). Hepatoprotective effect of apolipoprotein A4 against carbon tetrachloride induced acute liver injury through mediating hepatic antioxidant and inflammation response in mice. BIOCHEM BIOPH RES CO, 534 659-665. https://doi.org/10.1016/j.bbrc.2020.11.024IF: 2.5 Q3

3、Zhang, H., Zhang, S., Zhang, J., Zhou, R., Nie, Y., Ren, S., Li, J., Feng, K., Ji, F., Kong, G., Li, Z, (2019). Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism. PLATELETS, 31 (8), 1019-1027. https://doi.org/10.1080/09537104.2019.1704715

4、Lin, WB., Xu, GH., Zhang, GQ., Li, GT., Cui, GL., Liu, N., Zeng, FJ., Ai, ZG., Xu, GF., Liu, N., Liang, J., Zhang, MM., Li, C., Zhang, ZH., Wang, ZS., Li, Z., Yu, ZJ, (2020). Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: A multicentre, retrospective study. TRANSBOUND EMERG DIS, 67 (6), 2971-2982. https://doi.org/10.1111/tbed.13674IF: 3.5 Q1

5、Zheng, Z., Wang, H., Li, L., Zhang, S., Zhang, C., Zhang, H., Ji, F., Liu, X., Zhu, K., Kong, G., Li, Z, (2020). Splenectomy enhances the Ly6Clow phenotype in hepatic macrophages by activating the ERK1/2 pathway during liver fibrosis. INT IMMUNOPHARMACOL, 86 106762. https://doi.org/10.1016/j.intimp.2020.106762IF: 4.8 Q1

6、Li, BH., Jiang, W., Zhang, S., Huang, N., Sun, J., Yang, J., Li, ZF, (2020). The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice. MOL IMMUNOL, 125 95-103. https://doi.org/10.1016/j.molimm.2020.07.002IF: 3.2 Q2

7、Li, B., Chen, H., Shi, M., Huang, N., Kong, G., Li, Z, (2020). [Expression and significance of myeloid-derived suppressor cells-associated chemokine MIP-1γ and its receptor CCR1 in the spleen of hepatoma H22-bearing mice]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 36 (9), 802-808. PMID: 32967764

8、Wei, LL., Ma, N., Wu, KY., Wang, JX., Diao, TY., Zhao, SJ., Bai, L., Liu, E., Li, ZF., Zhou, W., Chen, D., Li, K, (2020). Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice. ARTERIOSCL THROM VAS, 40 (9), 2070-2083. https://doi.org/10.1161/ATVBAHA.120.314150IF: 7.4 Q1

9、Zhao, X., Zhang, Y., Ma, X., Chen, Y., Xi, J., Yin, X., Kang, H., Guan, H., Dai, Z., Liu, D., Zhao, F., Sun, C., Li, Z., Zhang, S, (2020). Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China. JPN J CLIN ONCOL, 50 (8), 852-858. https://doi.org/10.1093/jjco/hyaa051IF: 1.9 Q3

10、Zhu, K., Li, J., Li, J., Sun, J., Guo, Y., Tian, H., Li, L., Zhang, C., Shi, M., Kong, G., Li, Z, (2019). Ring1 promotes the transformation of hepatic progenitor cells into cancer stem cells through the Wnt/β-catenin signaling pathway. J CELL BIOCHEM, 121 (8-9), 3941-3951. https://doi.org/10.1002/jcb.29496IF: 3.0 Q3

11、Zu, J., Li, ML., Li, ZF., Shen, MW., Xiao, YN., Ji, FP, (2020). Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study. INFECT DIS POVERTY, 9 (1), 83. https://doi.org/10.1186/s40249-020-00709-zIF: 4.8 Q1

12、Ji, F., Li, L., Li, Z., Jin, Y., Liu, W, (2020). Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019. STEM CELL TRANSL MED, 9 (7), 813-814. https://doi.org/10.1002/sctm.20-0083IF: 5.4 Q1

13、Jiang, W., Li, Y., Wei, W., Li, JW., Li, L., Zhang, C., Zhang, SQ., Kong, GY., Li, ZF, (2020). Spleen contributes to restraint stress induced hepatocellular carcinoma progression. INT IMMUNOPHARMACOL, 83 106420. https://doi.org/10.1016/j.intimp.2020.106420IF: 4.8 Q1

14、Li, S., Huang, N., Dang, X., Li, L., Li, Z., Zhang, C., Jiang, A., Kong, G., Ji, F., Yang, J., Li, Z, (2020). A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syndrome Patients with Hypersplenism. VIRAL IMMUNOL, 33 (2), 112-121. https://doi.org/10.1089/vim.2019.0146IF: 1.5 Q4

15、Li, J., Li, R., Jiang, W., Sun, J., Li, J., Guo, Y., Zhu, K., Zhang, C., Kong, G., Li, Z, (2019). Splenic serum from portal hypertensive patients enhances liver stem cell proliferation and self-renewal via the IGF-II/ERK signaling pathway. DIGEST LIVER DIS, 52 (2), 205-213. https://doi.org/10.1016/j.dld.2019.07.014IF: 4.0 Q1

16、Guo, R., Tian, Y., Zhang, N., Huang, H., Huang, Y., Jin, X., Huang, X., Li, Z., Yang, J, (2020). Thymidylate synthase (TS) immunostaining in the diagnosis of the myoepithelial cells, basal cells, stratified epithelium cells, and associated tumors. TRANSL CANCER RES, 9 (2), 585-594. https://doi.org/10.21037/tcr.2019.12.18IF: 1.5 Q4

17、Yan, Y., Zhang, L., Tan, L., Ma, X., Zhang, Y., Shao, S., Liu, J., Xue, C., Li, Z., Zhang, X., Drokow, EK., Shi, X., Ren, J, (2018). Endocrine Therapy for Ductal Carcinoma In Situ (DCIS) of the Breast with Breast Conserving Surgery (BCS) and Radiotherapy (RT): a Meta-Analysis. PATHOL ONCOL RES, 26 (1), 521-531. https://doi.org/10.1007/s12253-018-0553-yIF: 2.3 Q2

18、Sun, J., Guo, Y., Bie, B., Zhu, M., Tian, H., Tian, J., Li, J., Yang, Y., Ji, F., Kong, G., Li, Z, (2019). Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway. J CELL BIOCHEM, 121 (1), 443-457. https://doi.org/10.1002/jcb.29206IF: 3.0 Q3

19、Li, BH., Garstka, MA., Li, ZF, (2019). Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor. MOL IMMUNOL, 117 201-215. https://doi.org/10.1016/j.molimm.2019.11.014IF: 3.2 Q2

20、Wang, B., Zhao, W., Liu, J., Chen, Y., Cao, X., Yang, Y., Zhang, Y., Wang, F., Zhang, P., Lei, B., Gu, L., Wang, J., Zhang, J., Zhang, R., Zhang, H., Shen, Y., Bai, J., Xu, Y., Wang, X., Zhang, R., Wei, L., Li, Z., He, G., Geng, Y., He, Q., Zhuang, Q., Fan, F., Zhang, W., He, A, (2019). Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) BLOOD, 134 (Supple1), 579-579. https://doi.org/10.1182/blood-2019-124953IF: 21.0 Q1

21、Zhou, R., Zhang, J., Bu, W., Zhang, W., Duan, B., Wang, X., Yao, L., Li, Z., Li, J, (2019). A New Role for the Spleen: Aggravation of the Systemic Inflammatory Response in Rats with Severe Acute Pancreatitis. AM J PATHOL, 189 (11), 2233-2245. https://doi.org/10.1016/j.ajpath.2019.07.008IF: 4.7 Q1

22、Wu, KY., Zhang, T., Zhao, GX., Ma, N., Zhao, SJ., Wang, N., Wang, JX., Li, ZF., Zhou, W., Li, K, (2019). The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice. KIDNEY INT, 96 (3), 612-627. https://doi.org/10.1016/j.kint.2019.03.005IF: 14.8 Q1

23、Ji, F., Yeo, YH., Wei, MT., Ogawa, E., Enomoto, M., Lee, DH., Iio, E., Lubel, J., Wang, W., Wei, B., Ide, T., Preda, CM., Conti, F., Minami, T., Bielen, R., Sezaki, H., Barone, M., Kolly, P., Chu, PS., Virlogeux, V., Eurich, D., Henry, L., Bass, MB., Kanai, T., Dang, S., Li, Z., Dufour, JF., Zoulim, F., Andreone, P., Cheung, RC., Tanaka, Y., Furusyo, N., Toyoda, H., Tamori, A., Nguyen, MH, (2019). Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis. J HEPATOL, 71 (3), 473-485. https://doi.org/10.1016/j.jhep.2019.04.017IF: 26.8 Q1

24、Jiang, W., Li, Y., Li, ZZ., Sun, J., Li, JW., Wei, W., Li, L., Zhang, C., Huang, C., Yang, SY., Yang, J., Kong, GY., Li, ZF, (2019). Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing splenic myeloid cells through activating β-adrenergic signaling. BRAIN BEHAV IMMUN, 80 825-838. https://doi.org/10.1016/j.bbi.2019.05.031IF: 8.8 Q1

25、Huang, N., Ji, FP., Zhang, S., Li, Z., Li, J., Zhou, R., Zhang, S., Wei, W., Li, L., Chen, H., Li, B., Kong, G., Yang, J., Li, Z, (2019). Spleen-Associated Effects on Immunity in Hepatitis B Virus-Related Cirrhosis with Portal Hypertension. J INTERF CYTOK RES, 39 (2), 95-105. https://doi.org/10.1089/jir.2018.0121IF: 1.9 Q4

26、Ji, F., Yeo, YH., He, C., Li, J., Gao, X., Li, Z., Henry, L., Nguyen, MH, (2018). Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment. J HEPATOL, 70 (1), 209-211. https://doi.org/10.1016/j.jhep.2018.09.016IF: 26.8 Q1

27、Li, B., Zhang, S., Huang, N., Chen, H., Wang, P., Yang, J., Li, Z, (2018). CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model. ONCOL REP, 41 (1), 608-618. https://doi.org/10.3892/or.2018.6809IF: 3.8 Q2